Suffern, NY, United States of America

Guy Thomas Carter

This inventor holds 1 USPTO granted patent. Top assignee: Roche Vitamins Inc.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guy Thomas Carter. Retrieved from https://idiyas.com/inventor/guy-thomas-carter-4xv9n279

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guy Thomas Carter: Innovator in Antibiotic Development

Introduction

Guy Thomas Carter is a notable inventor based in Suffern, NY (US). He has made significant contributions to the field of antibiotics, particularly with his invention of LL-E19020 Alpha.sub.1. This antibiotic is derived from the micro-organism Streptomyces lydicus ssp. tanzanius NRRL 18036, showcasing his innovative approach to combating bacterial infections.

Latest Patents

Carter holds 1 patent for his invention, which highlights his expertise and dedication to advancing medical science. The antibiotic LL-E19020 Alpha.sub.1 represents a promising development in the ongoing fight against antibiotic resistance.

Career Highlights

Throughout his career, Guy Thomas Carter has been associated with Roche Vitamins Inc., where he has contributed to various research initiatives. His work at Roche has allowed him to focus on the development of new antibiotics, which are crucial for public health.

Collaborations

Carter has collaborated with esteemed colleagues such as Joseph D. Korshalla and David R. Williams. These partnerships have enhanced his research efforts and contributed to the successful development of his antibiotic.

Conclusion

Guy Thomas Carter's innovative work in antibiotic development exemplifies the importance of research in addressing health challenges. His contributions continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…